The Manufacturers Life Insurance Company Invests $402,000 in Uranium Royalty Corp. $UROY

The Manufacturers Life Insurance Company acquired a new position in Uranium Royalty Corp. (NASDAQ:UROYFree Report) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 144,646 shares of the company’s stock, valued at approximately $402,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in UROY. Corient Private Wealth LLC bought a new stake in Uranium Royalty during the 2nd quarter valued at approximately $29,000. O Shaughnessy Asset Management LLC bought a new position in Uranium Royalty in the 4th quarter worth approximately $44,000. Thompson Davis & CO. Inc. bought a new position in Uranium Royalty in the 2nd quarter worth approximately $33,000. Financial Security Advisor Inc. purchased a new stake in Uranium Royalty during the 4th quarter valued at approximately $46,000. Finally, Squarepoint Ops LLC purchased a new stake in Uranium Royalty during the 3rd quarter valued at approximately $59,000. Institutional investors own 24.19% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently commented on UROY shares. HC Wainwright reissued a “buy” rating and issued a $4.50 target price on shares of Uranium Royalty in a report on Thursday, July 16th. Zacks Research raised shares of Uranium Royalty from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, July 14th. Weiss Ratings downgraded shares of Uranium Royalty from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, August 17th. Finally, National Bank Financial started coverage on shares of Uranium Royalty in a research note on Wednesday, July 29th. They issued an “outperform” rating and a $3.75 price target on the stock. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, Uranium Royalty has an average rating of “Buy” and a consensus target price of $4.12.

Get Our Latest Stock Report on UROY

Uranium Royalty Stock Performance

Shares of NASDAQ:UROY opened at $4.44 on Tuesday. The company has a market cap of $1.69 billion, a price-to-earnings ratio of 222.11 and a beta of 1.42. Uranium Royalty Corp. has a 12 month low of $2.56 and a 12 month high of $5.52. The company has a 50-day moving average price of $3.52 and a 200 day moving average price of $3.57.

About Uranium Royalty

(Free Report)

Uranium Royalty Corp. is a Vancouver-based mineral rights acquisition, royalty and streaming company focused exclusively on the uranium sector. Established in early 2021 and listed on the NASDAQ under the symbol UROY, the company seeks to provide investors with leveraged exposure to uranium prices without direct mining risk. Rather than owning or operating mines, Uranium Royalty acquires long-term royalties and streams on both production and development-stage uranium projects worldwide.

The company’s diversified portfolio encompasses royalty interests across multiple jurisdictions, including Canada, the United States, South America, Central Asia and Australia.

See Also

Want to see what other hedge funds are holding UROY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Uranium Royalty Corp. (NASDAQ:UROYFree Report).

Institutional Ownership by Quarter for Uranium Royalty (NASDAQ:UROY)

Receive News & Ratings for Uranium Royalty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uranium Royalty and related companies with MarketBeat.com's FREE daily email newsletter.